C.M. Bidwell & Associates’s AdaptHealth AHCO Stock Holding History

C.M. Bidwell & Associates’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-396	Closed	-$3.73K	–	488
2025 Q2	$3.73K	Hold	396	–	–	﹤0.01%	350
2025 Q1	$4.29K	Hold	396	–	–	﹤0.01%	323
2024 Q4	$3.77K	Hold	396	–	–	﹤0.01%	375
2024 Q3	$4.45K	Buy	+396	New	+$4.21K	﹤0.01%	345

Other funds holding AHCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

C.M. Bidwell & Associates's AHCO Position: Q3 2025 in Review

C.M. Bidwell & Associates sold out of AdaptHealth (AHCO) in Q3 2025, closing a stake of 396 shares — an estimated $3.73K sold.

C.M. Bidwell & Associates first reported a position in AHCO in Q3 2024 and held it in 4 quarters. The position peaked at $4.45K in Q3 2024. 225 funds tracked by Wall St. Rank hold AHCO as of Q3 2025.

C.M. Bidwell & Associates reported no remaining AdaptHealth position as of Q3 2025 after selling out during the quarter.
C.M. Bidwell & Associates sold 396 AdaptHealth shares in Q3 2025, an estimated $3.73K.
C.M. Bidwell & Associates first reported a position in AdaptHealth in Q3 2024 and held it in 4 quarters.
C.M. Bidwell & Associates's AdaptHealth position peaked at $4.45K in Q3 2024.
225 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2025.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2025, filed 13 Nov 2025.